Ad
related to: moderna
Search results
Moderna Has Big AI News. Is the Stock a Buy?
The Motley Fool via AOL· 59 minutes agoModerna (NASDAQ: MRNA) isn't new to artificial intelligence (AI). The biotech best known for its billion-dollar coronavirus vaccine has been using this...
Moderna Announces Data to be Presented at 2024 ASCO Annual Meeting
The Sacramento Bee· 1 hour agoModerna to host an investor event via webcast on Monday, June 3 at 6:15 PM CDT
Selling US$3.3m Of Moderna Stock Rewarded Insiders
Simply Wall St. via Yahoo Finance· 22 hours agoModerna, Inc.'s (NASDAQ:MRNA) stock rose 12% last week, but insiders who sold US$3.3m worth of stock over the last year are probably in a more...
Moderna and Novavax Hope for Early Launch of This Year’s Covid-19 Shots, Despite FDA Delay
Barrons.com· 2 days agoVaccine makers Moderna and Novavax are hoping for an August rollout this year, earlier than last...
Moderna’s Push to Personalize Cancer Treatments
Bloomberg· 1 day agoHi, it’s Gerry in New York. I recently toured Moderna’s manufacturing facility to see how they make personalized cancer vaccines. But first ...
Robeco Institutional Asset Management B.V. Decreases Stake in Moderna, Inc. (NASDAQ:MRNA)
ETF DAILY NEWS· 1 day agoRobeco Institutional Asset Management B.V. lowered its position in Moderna, Inc. (NASDAQ:MRNA – Free Report) by 51.1% in the 4th quarter, according to the company in its most ...
Does AI Really Make Moderna Stock (NASDAQ:MRNA) a Buy?
TipRanks via Yahoo Finance· 5 days agoModerna (NASDAQ:MRNA) stock has collapsed from its all-time high. However, the company is once again...
Could Novavax Become the Next Moderna?
The Motley Fool via AOL· 5 days agoNovavax (NASDAQ: NVAX) and Moderna (NASDAQ: MRNA) both entered the coronavirus vaccine race around the same time, in early pandemic days, and their...
The Highest Paid CEOs of 2023
The Wall Street Journal· 1 day agoPoor performance can slash the value of CEO equity awards. Covid-vaccine maker Moderna reported total pay of $17.1 million for CEO Stéphane Bancel last...
European Patent Office Sides with Moderna In COVID-19 Vaccine Patent Dispute With Pfizer/BioNTech
Benzinga via AOL· 5 days agoModerna Inc (NASDAQ:MRNA) has reportedly achieved a significant victory at the European Patent...
